(Q37096960)

English

The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial

scientific article published on 30 June 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Saundra S. Buys

7

object named as

Saundra S Buys

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

author name string

Christine C Johnson

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Bruce Kessel

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Thomas L Riley

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Lawrence R Ragard

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Craig R Williams

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Jian-Lun Xu

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Prostate, Lung, Colorectal and Ovarian Cancer Project Team

8

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

language of work or name

0 references

publication date

30 June 2008

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

110

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

383-389

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Recruitment in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: the first phase of recruitment at Henry Ford Health System.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744195

29 September 2017

Cancer statistics, 2006

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744195

29 September 2017

New tumor markers: CA125 and beyond.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744195

29 September 2017

Potential markers that complement expression of CA125 in epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744195

29 September 2017

Role of leptin in the regulation of body fluid volume and pressures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744195

29 September 2017

Current status of the molecular characterization of the ovarian cancer antigen CA125 and implications for its use in clinical screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744195

29 September 2017

Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744195

29 September 2017

The CA 125 gene: an extracellular superstructure dominated by repeat sequences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744195

29 September 2017

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744195

29 September 2017

Ovarian cancer tumor marker behavior in asymptomatic healthy women: implications for screening.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744195

29 September 2017

CA 125: fundamental and clinical aspects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744195

29 September 2017

Determination of a normal level of serum CA125 in postmenopausal women as a tool for preoperative evaluation and postoperative surveillance of endometrial carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744195

27 June 2018

Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744195

3 September 2018

Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744195

3 September 2018

Effect of hormone replacement therapy on serum levels of tumor markers in healthy postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744195

3 September 2018

Influence of exogenous estrogen administration on serum CA-125 originating from the endometrium.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744195

3 September 2018

Factors influencing serum CA125II levels in healthy postmenopausal women.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744195

3 September 2018

Evidence of a Healthy Volunteer Effect in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744195

4 December 2018

CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.006

7 January 2021

The quest for ovarian cancer's Holy Grail: can CA-125 still be the chalice of early detection?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.006

7 January 2021

Serum CA 125 concentrations in women of different ages, hormonal statuses, orclinical conditions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.006

7 January 2021

Serum CA-125 in Relation to Adnexal Dysplasia and Cancer in Women at Hereditary High Risk of Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.006

7 January 2021

Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.006

7 January 2021

Tumor marker CA-125 in tissues of the female reproductive tract and in serum during the normal menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.006

7 January 2021

An evaluation of CA125 levels in 291 normal postmenopausal and 20 endometrial adenocarcinoma-bearing women before and after surgery

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.006

7 January 2021

Serum tumor marker immunoassays in gynecologic oncology: establishment of reference values

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.006

7 January 2021

A prospective randomized controlled study comparing the morphological and biochemical responses of the endometrium to two different forms of 'period-free' hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.006

7 January 2021

Obesity-induced hypertension. Renal function and systemic hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.006

7 January 2021

Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.006

7 January 2021

Factors influencing serum CA 125 levels in normal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/18586313

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.YGYNO.2008.05.006

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37096960&oldid=2214380094"